Provided by Tiger Trade Technology Pte. Ltd.

Alcon Inc.

78.83
+0.46000.59%
Post-market: 78.830.00000.00%17:43 EST
Volume:2.09M
Turnover:163.47M
Market Cap:38.71B
PE:37.54
High:78.89
Open:77.44
Low:77.44
Close:78.37
52wk High:99.20
52wk Low:71.55
Shares:491.00M
Float Shares:491.00M
Volume Ratio:0.96
T/O Rate:0.43%
Dividend:0.34
Dividend Rate:0.44%
EPS(TTM):2.10
EPS(LYR):2.06
ROE:4.82%
ROA:2.62%
PB:1.75
PE(LYR):38.28

Loading ...

Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems

Benzinga_recent_news
·
Jan 31

Alcon AG : William Blair Initiates Coverage With Market Perform Rating

THOMSON REUTERS
·
Jan 30

BTIG Sticks to Its Buy Rating for Alcon (ALC)

TIPRANKS
·
Jan 27

Alcidion Group Limited (ALC) Gets a Buy from Bell Potter

TIPRANKS
·
Jan 16

Alcidion Group (ASX:ALC) Is Up 8.7% After Returning To Profit On UK Healthcare IT Contracts

Simply Wall St.
·
Jan 16

Alcidion Group Limited (ASX:ALC) Surges 33% Yet Its Low P/S Is No Reason For Excitement

Simply Wall St.
·
Jan 15

Alcidion Group Limited (ALC) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Jan 13

Alcidion Group Limited's (ASX:ALC) 15% gain last week benefited both individual investors who own 56% as well as insiders

Simply Wall St.
·
Jan 10

Alcon Cut to Hold From Buy by Stifel

Dow Jones
·
Jan 09

U.S. RESEARCH ROUNDUP-Ardelyx, RPM International, Trubridge

Reuters
·
Jan 09

RBC Capital Reaffirms Their Hold Rating on Alcidion Group Limited (ALC)

TIPRANKS
·
Jan 09

Alcon Terminates Merger Deal With STAAR Surgical

MT Newswires Live
·
Jan 07

Press Release: Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon

Dow Jones
·
Jan 06

Press Release: Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon

Dow Jones
·
Dec 20, 2025

Press Release: Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

Dow Jones
·
Dec 20, 2025

Press Release: STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

Dow Jones
·
Dec 17, 2025

Press Release: Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory

Dow Jones
·
Dec 17, 2025

Press Release: Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

Dow Jones
·
Dec 16, 2025

Press Release: Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

Dow Jones
·
Dec 16, 2025

Press Release: Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote "FOR" Alcon Merger

Dow Jones
·
Dec 16, 2025